Home Archives Samsung Biologics Reports First Quarter 2026 Financial Results Samsung Biologics Reports First Quarter 2026 Financial ResultsApril 21, 2026 B Recorded Q1’26 revenue of KRW 1,257 billion and operating profit of KRW 581 billion Performance driven by full utilization across Plants 1 through 4… Login to continue reading Login Sign up for complimentary access Sign Up Now Close posteditor Articles: 21727 Previous Post NEW TELE-DENTISTRY PROGRAMME SUPPORTS EARLY INTERVENTION FOR CHILDREN AT RISK OF CARIES Next Post Iconic British Brand Laura Ashley launches Four Fragrances Inspired by Archival Prints